SS Innovations International Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (SRIA), receiving recognition from the industry organization for its work in developing and commercializing robotic surgery technology. The company was selected over nine other finalists, including several established medical technology companies active in robotic surgery.
The award comes as adoption of the SSi Mantra surgical robotic system continues to expand, with more than 11,700 procedures completed globally. SSi Mantra has received regulatory approvals in 14 countries, supporting the company’s international growth strategy. More than 2,100 physicians have been trained on the company’s robotic surgery platform, which has been used across more than 170 different procedures.
For investors, the recognition provides an independent industry endorsement as SS Innovations continues to expand its presence in the rapidly growing global surgical robotics market. The surgical robotics industry has become increasingly competitive as healthcare providers adopt robotic-assisted procedures across multiple specialties and manufacturers seek to expand beyond traditional markets.
SS Innovations is a developer of innovative surgical robotic technologies, and this award underscores its progress in a field where technological advancement and clinical adoption are key to success. The company’s newsroom provides the latest updates (https://ibn.fm/SSII).
